Abstract
Background: Antidepressants are widely used to treat adolescent depression, despite ongoing debates regarding their efficacy for youth. In this back and forth, surprisingly little attention has been paid to measurement issues. Though seemingly basic, careful consideration of measure selection and related assessment decisions is critical to evaluating antidepressants as a treatment option for adolescents.
Objectives: The objectives of the current review are to 1) highlight the psychometric quality of commonly used assessment measures in randomized controlled trials (RCTs) and 2) discuss pertinent assessment issues that may impact conclusions drawn regarding antidepressant efficacy. These issues include consistency of findings across measures, selection of an index of symptom change, choice of symptom reporter, and time to assessment follow-up.
Methods: This review discusses the quality of widely used assessment measures and highlights how findings from RCTs differ based on assessment decisions.
Conclusion: Measures and measurement decisions impact conclusions drawn when evaluating antidepressant effectiveness. Even some of the most commonly used measures in RCTs have limited evidence for reliability and validity, calling into question findings derived from those measures. Additionally, antidepressants are inconsistently found to outperform placebo, with only a quarter of comparisons finding antidepressants to be statistically superior. Results are even less promising when looking at youth- or parent-report and longterm follow-ups. The review concludes by providing suggestions for improving assessment of antidepressant effectiveness for youth.
Keywords: Assessment of treatment efficacy, adolescent depression, antidepressants, selective serotonin reuptake inhibitors, RCTS, children depression.
Adolescent Psychiatry
Title:Measurement Matters in Evaluating Youth Antidepressant Effectiveness
Volume: 8 Issue: 2
Author(s): Hannah R. Lawrence*, Douglas W. Nangle and Michelle L. Buffie
Affiliation:
- University of Maine, Orono, Maine,United States
Keywords: Assessment of treatment efficacy, adolescent depression, antidepressants, selective serotonin reuptake inhibitors, RCTS, children depression.
Abstract: Background: Antidepressants are widely used to treat adolescent depression, despite ongoing debates regarding their efficacy for youth. In this back and forth, surprisingly little attention has been paid to measurement issues. Though seemingly basic, careful consideration of measure selection and related assessment decisions is critical to evaluating antidepressants as a treatment option for adolescents.
Objectives: The objectives of the current review are to 1) highlight the psychometric quality of commonly used assessment measures in randomized controlled trials (RCTs) and 2) discuss pertinent assessment issues that may impact conclusions drawn regarding antidepressant efficacy. These issues include consistency of findings across measures, selection of an index of symptom change, choice of symptom reporter, and time to assessment follow-up.
Methods: This review discusses the quality of widely used assessment measures and highlights how findings from RCTs differ based on assessment decisions.
Conclusion: Measures and measurement decisions impact conclusions drawn when evaluating antidepressant effectiveness. Even some of the most commonly used measures in RCTs have limited evidence for reliability and validity, calling into question findings derived from those measures. Additionally, antidepressants are inconsistently found to outperform placebo, with only a quarter of comparisons finding antidepressants to be statistically superior. Results are even less promising when looking at youth- or parent-report and longterm follow-ups. The review concludes by providing suggestions for improving assessment of antidepressant effectiveness for youth.
Export Options
About this article
Cite this article as:
Lawrence R. Hannah *, Nangle W. Douglas and Buffie L. Michelle, Measurement Matters in Evaluating Youth Antidepressant Effectiveness, Adolescent Psychiatry 2018; 8 (2) . https://dx.doi.org/10.2174/2210676608666180620143953
DOI https://dx.doi.org/10.2174/2210676608666180620143953 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Endothelial Dysfunction: Methods of Assessment & Implications for Cardiovascular Diseases
Current Pharmaceutical Design Magnetic Nanoparticles: New Players in Antimicrobial Peptide Therapeutics.
Current Protein & Peptide Science Novel Non-Steroidal Anti-Inflammatory Drugs: What we have Learned from Animal Studies
Current Drug Targets - Inflammation & Allergy Formulation and Evaluation of α-Pinene Loaded Self-emulsifying Nanoformulation for <i>In-Vivo</i> Anti-Parkinson's Activity
Recent Patents on Nanotechnology L1CAM Beneficially Inhibits Histone Deacetylase 2 Expression under Conditions of Alzheimer’s Disease
Current Alzheimer Research Nanofillers for Food Packaging: Antimicrobial Potential of Metal-based Nanoparticles
Current Nanotoxicity and Prevention (Discontinued) Cyclic Dipeptides: Secondary Metabolites Isolated from Different Microorganisms with Diverse Biological Activities
Current Medicinal Chemistry Molecular Mechanisms of Ischemic Neuronal Cell Death - With Relevance to Alzheimers Disease
Current Alzheimer Research Combining Stress and Dopamine Based Models of Addiction: Towards a Psycho-Neuro-Endocrinological Theory of Addiction
Current Drug Abuse Reviews Neuregulin1 as Novel Therapy for Heart Failure
Current Pharmaceutical Design Targeting Allosteric Control Mechanisms in Heat Shock Protein 70 (Hsp70)
Current Topics in Medicinal Chemistry Molecular Modeling of Benzimidazole Derivatives: A Promising Series of GluN2B Selective NMDA Receptor Antagonists
Current Drug Therapy Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects
Current Medicinal Chemistry Puerarin: A Review on the Pharmacological Activity, Chemical Properties and Pharmacokinetics of Main Isoflavonoid
The Natural Products Journal Therapeutic Chelators for the Twenty First Century: New Treatments for Iron and Copper Mediated Inflammatory and Neurological Disorders
Current Drug Delivery First Synthesis of 5- and 7-Phenylethynyl-8-hydroxyquinolines by Sonogashira Reaction
Letters in Organic Chemistry Involvement of the Toxic AGEs (TAGE)-RAGE System in the Pathogenesis of Diabetic Vascular Complications: A Novel Therapeutic Strategy
Current Drug Targets Drugs of Abuse, Driving and Traffic Safety
Current Drug Abuse Reviews Structural MRI Biomarkers of Mild Cognitive Impairment from Young Elders to Centenarians
Current Alzheimer Research Molecular Dynamics in Esophageal Adenocarcinoma: Who’s in Control?
Current Cancer Drug Targets